Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Index by author

May 2025; Volume 45,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Akhter, ARIZ

    1. You have access
      HOX-PBX Up-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AML via WNT Signaling
      GHALEB ELYAMANY, SULTAN ALOTAIBI, BANDER ALHARBI, OSAMA ATALLAH ALHAFI, HASSAN ALJASEM, HADI JAMIL, TARIQ M. ROSHAN, ARIZ AKHTER and ADNAN MANSOOR
      Anticancer Research May 2025, 45 (5) 2079-2089; DOI: https://doi.org/10.21873/anticanres.17582
  2. Alhafi, OSAMA ATALLAH

    1. You have access
      HOX-PBX Up-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AML via WNT Signaling
      GHALEB ELYAMANY, SULTAN ALOTAIBI, BANDER ALHARBI, OSAMA ATALLAH ALHAFI, HASSAN ALJASEM, HADI JAMIL, TARIQ M. ROSHAN, ARIZ AKHTER and ADNAN MANSOOR
      Anticancer Research May 2025, 45 (5) 2079-2089; DOI: https://doi.org/10.21873/anticanres.17582
  3. Alharbi, BANDER

    1. You have access
      HOX-PBX Up-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AML via WNT Signaling
      GHALEB ELYAMANY, SULTAN ALOTAIBI, BANDER ALHARBI, OSAMA ATALLAH ALHAFI, HASSAN ALJASEM, HADI JAMIL, TARIQ M. ROSHAN, ARIZ AKHTER and ADNAN MANSOOR
      Anticancer Research May 2025, 45 (5) 2079-2089; DOI: https://doi.org/10.21873/anticanres.17582
  4. Aljasem, HASSAN

    1. You have access
      HOX-PBX Up-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AML via WNT Signaling
      GHALEB ELYAMANY, SULTAN ALOTAIBI, BANDER ALHARBI, OSAMA ATALLAH ALHAFI, HASSAN ALJASEM, HADI JAMIL, TARIQ M. ROSHAN, ARIZ AKHTER and ADNAN MANSOOR
      Anticancer Research May 2025, 45 (5) 2079-2089; DOI: https://doi.org/10.21873/anticanres.17582
  5. Alotaibi, SULTAN

    1. You have access
      HOX-PBX Up-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AML via WNT Signaling
      GHALEB ELYAMANY, SULTAN ALOTAIBI, BANDER ALHARBI, OSAMA ATALLAH ALHAFI, HASSAN ALJASEM, HADI JAMIL, TARIQ M. ROSHAN, ARIZ AKHTER and ADNAN MANSOOR
      Anticancer Research May 2025, 45 (5) 2079-2089; DOI: https://doi.org/10.21873/anticanres.17582
  6. Ampil, FEDERICO

    1. You have access
      Palliative Radiotherapy for Large Osteolytic Metastatic Tumors Involving the Iliac Bone: A Report of 16 Cases
      FEDERICO AMPIL, RUSSELL ANDERSON, TROY RICHARDS, CARRIE PORTER and MICHELLE NORTON
      Anticancer Research May 2025, 45 (5) 2103-2108; DOI: https://doi.org/10.21873/anticanres.17584
  7. Anderson, RUSSELL

    1. You have access
      Palliative Radiotherapy for Large Osteolytic Metastatic Tumors Involving the Iliac Bone: A Report of 16 Cases
      FEDERICO AMPIL, RUSSELL ANDERSON, TROY RICHARDS, CARRIE PORTER and MICHELLE NORTON
      Anticancer Research May 2025, 45 (5) 2103-2108; DOI: https://doi.org/10.21873/anticanres.17584
  8. Aoki, MASANORI

    1. You have access
      Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia
      MASANORI AOKI, HIROSHI MATSUI, SOTA KURIHARA, NOBUAKI OHTAKE, SHUN NAKAZAWA, YUSUKE TSUJI, YUJI FUJIZUKA, SEIJI ARAI, MASASHI NOMURA, YOSHITAKA SEKINE, HIDEKAZU KOIKE, KAZUHIRO SUZUKI and YOSHIYUKI MIYAZAWA
      Anticancer Research May 2025, 45 (5) 2195-2204; DOI: https://doi.org/10.21873/anticanres.17593
  9. Aoki, TAKESHI

    1. Open Access
      Rare Upper Mediastinal Oligometastasis from Early Esophagogastric Adenocarcinoma: A Case Report
      LARRY WENG-HONG LAI, TAKESHI YAMASHITA, KOJI OTSUKA, AKIRA SAITO, MASAHIRO KOHMOTO, KENTARO MOTEGI, TOMOTAKE ARIYOSHI, SATORU GOTO, MASAHIKO MURAKAMI and TAKESHI AOKI
      Anticancer Research May 2025, 45 (5) 2109-2114; DOI: https://doi.org/10.21873/anticanres.17585
    2. Open Access
      Efficacy of Esophagectomy Following Neoadjuvant Chemotherapy for Esophageal Neuroendocrine Carcinoma
      TAKESHI YAMASHITA, KOICHIRO FUJIMASA, KOJI OTSUKA, AKIRA SAITO, MASAHIRO KOHMOTO, KENTARO MOTEGI, TOMOTAKE ARIYOSHI, SATORU GOTO, TOSHIKO YAMOCHI, MASAFUMI TAKIMOTO, YUYA HIRASAWA, YUTARO KUBOTA, KIYOSHI YOSHIMURA, TAKUYA TSUNODA, MASAHIKO MURAKAMI and TAKESHI AOKI
      Anticancer Research May 2025, 45 (5) 2051-2058; DOI: https://doi.org/10.21873/anticanres.17579
  10. Arai, SEIJI

    1. You have access
      Comparison of BRCA2 Single Nucleotide Variants Between Japanese Patients With Familial Prostate Cancer, Sporadic Prostate Cancer, and Benign Prostatic Hyperplasia
      MASANORI AOKI, HIROSHI MATSUI, SOTA KURIHARA, NOBUAKI OHTAKE, SHUN NAKAZAWA, YUSUKE TSUJI, YUJI FUJIZUKA, SEIJI ARAI, MASASHI NOMURA, YOSHITAKA SEKINE, HIDEKAZU KOIKE, KAZUHIRO SUZUKI and YOSHIYUKI MIYAZAWA
      Anticancer Research May 2025, 45 (5) 2195-2204; DOI: https://doi.org/10.21873/anticanres.17593
« Previous (Pages : 1 2 3 4 5 6 ... 29) Next »
Back to top
Previous

In this issue

Anticancer Research: 45 (5)
Anticancer Research
Vol. 45, Issue 5
May 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Reduces Aggressiveness of Cervical Carcinoma Cells
  • Long-term Outcomes of Helical Tomotherapy in Lymph Node-positive Breast Cancer Following Breast-conserving Surgery
  • Ubiquitin-proteasome Pathway-linked Gene Signatures as Prognostic Indicators in Prostate Cancer
  • Role of Stromal CD25+/CD8+ Lymphocyte Ratio in Patients With Grade 2-3 Cervical Intraepithelial Neoplasia (CIN 2-3): A Retrospective Single-center Study
  • Advantages and Disadvantages of Drug Combination Treatment: Riluzole, Metformin and Dexamethasone Effect on Glioblastoma Cell
Sign up for alerts
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire